Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial

E. Kneppers, B. van der Holt, M.J. Kersten, S. Zweegman, E. Meijer, G. Huls, J.J. Cornelissen, J.J.W.M. Janssen, C. Huisman, P.B. Cornelisse, C.P. Bruijnen, M. Emmelot, P. Sonneveld, H.M. Lokhorst, T. Mutis, M.C. Minnema

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2413-2419
JournalBlood
Volume118
Issue number9
DOIs
Publication statusPublished - 2011

Cite this

Kneppers, E. ; van der Holt, B. ; Kersten, M.J. ; Zweegman, S. ; Meijer, E. ; Huls, G. ; Cornelissen, J.J. ; Janssen, J.J.W.M. ; Huisman, C. ; Cornelisse, P.B. ; Bruijnen, C.P. ; Emmelot, M. ; Sonneveld, P. ; Lokhorst, H.M. ; Mutis, T. ; Minnema, M.C. / Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial. In: Blood. 2011 ; Vol. 118, No. 9. pp. 2413-2419.
@article{98b665ae41aa408bab71e398018d0e54,
title = "Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial",
author = "E. Kneppers and {van der Holt}, B. and M.J. Kersten and S. Zweegman and E. Meijer and G. Huls and J.J. Cornelissen and J.J.W.M. Janssen and C. Huisman and P.B. Cornelisse and C.P. Bruijnen and M. Emmelot and P. Sonneveld and H.M. Lokhorst and T. Mutis and M.C. Minnema",
year = "2011",
doi = "10.1182/blood-2011-04-348292",
language = "Undefined/Unknown",
volume = "118",
pages = "2413--2419",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "9",

}

Kneppers, E, van der Holt, B, Kersten, MJ, Zweegman, S, Meijer, E, Huls, G, Cornelissen, JJ, Janssen, JJWM, Huisman, C, Cornelisse, PB, Bruijnen, CP, Emmelot, M, Sonneveld, P, Lokhorst, HM, Mutis, T & Minnema, MC 2011, 'Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial' Blood, vol. 118, no. 9, pp. 2413-2419. https://doi.org/10.1182/blood-2011-04-348292

Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial. / Kneppers, E.; van der Holt, B.; Kersten, M.J.; Zweegman, S.; Meijer, E.; Huls, G.; Cornelissen, J.J.; Janssen, J.J.W.M.; Huisman, C.; Cornelisse, P.B.; Bruijnen, C.P.; Emmelot, M.; Sonneveld, P.; Lokhorst, H.M.; Mutis, T.; Minnema, M.C.

In: Blood, Vol. 118, No. 9, 2011, p. 2413-2419.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial

AU - Kneppers, E.

AU - van der Holt, B.

AU - Kersten, M.J.

AU - Zweegman, S.

AU - Meijer, E.

AU - Huls, G.

AU - Cornelissen, J.J.

AU - Janssen, J.J.W.M.

AU - Huisman, C.

AU - Cornelisse, P.B.

AU - Bruijnen, C.P.

AU - Emmelot, M.

AU - Sonneveld, P.

AU - Lokhorst, H.M.

AU - Mutis, T.

AU - Minnema, M.C.

PY - 2011

Y1 - 2011

U2 - 10.1182/blood-2011-04-348292

DO - 10.1182/blood-2011-04-348292

M3 - Article

VL - 118

SP - 2413

EP - 2419

JO - Blood

JF - Blood

SN - 0006-4971

IS - 9

ER -